Course Access
Forum Replies Created
-
Posts
-
Id be interested to hear if anyone is aware of the reason for the change from 250 to 300mm as I doubt very much that this is evidence-based.
My understanding is that there is no requirement to retrospectively alter facilities or fittings to comply with new versions of AusHFG if changes are made, but that new builds or renovations ought to be designed to comply.
Looking forward to seeing other thoughts and comments in response to your question.Joanna Harris
Nurse Manager, ISLHD Infection Management and Control Service (IMACS)
Telephone – mobile 0475 943494 / Wollongong office 4222 5898 / Warrawong office 4221 6820
Joanna.Harris@health.nsw.gov.au
http://www.health.nsw.gov.au[http://www.who.int/entity/gpsc/5may/MAIN1.jpg?ua=1]
http://www.who.int/gpsc/5may/patient-tips.pdf?ua=1
From: ACIPC Infexion Connexion [mailto:AICALIST@AICALIST.ORG.AU] On Behalf Of Mary Willimann (Subiaco)
Sent: Friday, 9 February 2018 4:35 PM
To: AICALIST@AICALIST.ORG.AU
Subject: Sterile storage areasHi Everyone
I am hoping that you might be able to provide some expert advice/references regarding the height of lowest shelf in sterile storage areas.
I am aware that the AHIA, AusHFG Part D: Infection Prevention and Control, now stipulate 300mm above the floor but I cant seem to find any other references that mention specific heights. Also the disclaimer at the beginning of Part D states:
AHIA gives no warranty or guarantee that the information in the AusHFG is correct, complete or otherwise suitable for use. AHIA shall not be liable for any loss howsoever caused whether due to negligence or otherwise arising from the use of or reliance on this information.
AHIA recommends that those seeking to rely on the information in the AusHFG obtain their own independent expert advice
All of our shelves in Theatre are currently still 250mm above the floor, so to change them all over would be a significant task.
Any advice would be very welcome.
Kind regards
MaryMary Willimann CICP-E | Manager Infection Prevention & Control
St John of God Subiaco Hospital
T: (08) 9382 6871 | M: 0439993772 | F: (08) 9382 6785 | E: Mary.Willimann@sjog.org.au
12 Salvado Road Subiaco WA 6008 | PO Box 14, Subiaco WA 6904
http://sjog.org.au/subiaco | http://twitter.com/sjog_healthcare | LinkedIn | http://facebook.com/StJohnOfGodSubiacoHospital[cid:image001.png@01D3A1AA.BC126230]
We acknowledge the Traditional Owners of Country throughout Australia and recognise their continuing connection to land, waters and community.
We pay our respect to them and their cultures and to Elders past and present.IMPORTANT: This email and any attachments are for the sole use of the intended recipient. They may contain confidential or privileged information. This information may not necessarily be the view of St John of God Health Care Inc (SJGHC). SJGHC does not warrant, represent or guarantee the accuracy or completeness of the information. SJGHC does not accept liability for any loss or damage in connection with the information. If you are not the intended recipient then any use, reliance, interference with, disclosure, distribution or copying of this information by you is unauthorised and prohibited. If you have received this email in error then please notify the sender by return email and delete all copies. SJGHC does not waive any privilege.
MESSAGES POSTED TO THIS LIST ARE SOLELY THE OPINION OF THE AUTHOR, AND DO NOT REPRESENT THE OPINION OF ACIPC.The use of trade/product/commercial brand names through the list is discouraged by ACIPC. If you wish to discuss specific reference to products or services by brand or commercial names, please do this outside the list.
Archive of all messages are available at http://aicalist.org.au/archives – registration and login required.
Replies to this message will be directed back to the list. To create a new message send an email to aicalist@aicalist.org.au
To send a message to the list administrator send an email to aicalist-request@aicalist.org.au.
You can unsubscribe from this list be sending ‘signoff aicalist’ (without the quotes) to listserv@aicalist.org.au
This message is intended for the addressee named and may contain confidential information. If you are not the intended recipient, please delete it and notify the sender.
Views expressed in this message are those of the individual sender, and are not necessarily the views of NSW Health or any of its entities.
MESSAGES POSTED TO THIS LIST ARE SOLELY THE OPINION OF THE AUTHOR, AND DO NOT REPRESENT THE OPINION OF ACIPC.
The use of trade/product/commercial brand names through the list is discouraged by ACIPC. If you wish to discuss specific reference to products or services by brand or commercial names, please do this outside the list.
Archive of all messages are available at http://aicalist.org.au/archives – registration and login required.
Replies to this message will be directed back to the list. To create a new message send an email to aicalist@aicalist.org.au
To send a message to the list administrator send an email to aicalist-request@aicalist.org.au.
You can unsubscribe from this list be sending ‘signoff aicalist
HI Lindy,
Our Wound Care CNC has recently asked us the same question. The guideline seems quite useful but we have concerns about the advice that discusses the practice of cutting dressings down to size and using the ‘opened but not used’ remainder for future dressing changes. Sections 5, 6 and 7 are the relevant ones.
What are others’ thoughts?Joanna Harris
Nurse Manager, ISLHD Infection Management and Control Service (IMACS)
Telephone – mobile 0475 943494 / Wollongong office 4222 5898 / Warrawong office 4221 6820
Joanna.Harris@health.nsw.gov.au
http://www.health.nsw.gov.au[http://www.who.int/entity/gpsc/5may/MAIN1.jpg?ua1]
http://www.who.int/gpsc/5may/patient-tips.pdf?ua1
Hello
hope you are all having a lovey day
Just wondering if anyone has come across this 2017 document developed by Wounds Australia called the ‘application of aseptic technique in wound dressing procedure’.
It is a consensus document put out by Wound Australiana that I have been approached by staff in regards to them in using & developing local processes and procedures .I am uncertain with whom they may have consulted with from Infection control perspective in developing their consensus as on face value it looks like a useful resource… what are others thoughts?
kind regards
Lindy
Lindy Ryan
District Infection Prevention & Control CNC | Clinical Governance Unit MNCLHD
Level 1 Coffs Specialist Centre, Pacific Hwy, Coffs Harbour
Mob 0419 990 693 | lindy.ryan@ncahs.health.nsw.gov.au
http://www.health.nsw.gov.au[http://internal.health.nsw.gov.au/communications/e-signatures/images/NSW-Health-Mid-North-Coast-LHD.jpg]
“Wise and humane management of the patient is the best safeguard against infection”
(Florence Nightingale Circa 1860)________________________________
This message is intended for the addressee(s) named and may contain confidential information. If you are not the intended recipient, please delete the message and any attachments and notify the sender. Views expressed in this message are those of the individual sender, and are not necessarily the views of NSW Health or any of its entities.
MESSAGES POSTED TO THIS LIST ARE SOLELY THE OPINION OF THE AUTHOR, AND DO NOT REPRESENT THE OPINION OF ACIPC.The use of trade/product/commercial brand names through the list is discouraged by ACIPC. If you wish to discuss specific reference to products or services by brand or commercial names, please do this outside the list.
Archive of all messages are available at http://aicalist.org.au/archives – registration and login required.
Replies to this message will be directed back to the list. To create a new message send an email to aicalist@aicalist.org.au
To send a message to the list administrator send an email to aicalist-request@aicalist.org.au.
You can unsubscribe from this list be sending ‘signoff aicalist’ (without the quotes) to listserv@aicalist.org.au
This message is intended for the addressee named and may contain confidential information. If you are not the intended recipient, please delete it and notify the sender.
Views expressed in this message are those of the individual sender, and are not necessarily the views of NSW Health or any of its entities.
MESSAGES POSTED TO THIS LIST ARE SOLELY THE OPINION OF THE AUTHOR, AND DO NOT REPRESENT THE OPINION OF ACIPC.
The use of trade/product/commercial brand names through the list is discouraged by ACIPC. If you wish to discuss specific reference to products or services by brand or commercial names, please do this outside the list.
Archive of all messages are available at http://aicalist.org.au/archives – registration and login required.
Replies to this message will be directed back to the list. To create a new message send an email to aicalist@aicalist.org.au
To send a message to the list administrator send an email to aicalist-request@aicalist.org.au.
You can unsubscribe from this list be sending ‘signoff aicalist’ (without the quotes) to listserv@aicalist.org.au
As I was unfortunately unable to be at the conference I’d be interested to know what the issue with this is, and whether infection prevention and control concerns have been identified as theoretical or real issues.
Just this afternoon I have been asked to advise about the use of infacol by endoscopists. Apparently the intention is to reduce the development of mucus ‘bubbles’ that could obscure the field of vision.
Our endoscopy unit staff are concerned about a build-up of residue and possible biofilm in the CO2/water channels and on the tubing leading from the CO2 bottles to the ‘scope. They are also finding that insufflation seems to have been affected recently and think it might be due to a greasy coating affecting valves and seals etc.Although there are clearly a few non-IPC issues here, I am hoping to be able to answer infection control-related concerns.
Has anybody had any experience of the use of infacol in CO2 and/or water channels confirmed as leading to the transmission of pathogens, or ineffective reprocessing?
Thanks in anticipation 🙂Jo Harris
Nurse Manager, Illawarra Shoalhaven Local Health District Infection Management and Control Service (IMACS)
Telephone – mobile 0475 943494 / Wollongong office 02 4222 5898 / Warrawong office 02 4221 6820
Joanna.Harris@health.nsw.gov.au
http://www.health.nsw.gov.au[http://www.health.nsw.gov.au/images/communications/e-signatures/images/NSW-Health-Master.jpg]
Dear members
At the recent ACIPC conference in Melbourne there was some discussion about using “infacol” during endoscopy and the risk of developing biofilm in the channels.Does anyone have any literature regarding this so I can show one of my general surgeons – who doesn’t seem to think this is an issue!
Thanks
JennyKind regards,
Jenny McCarthy
Operating Room Manger/Infection Prevention and Control Coordinator
Maryvale Private Hospital
PO Box 348, Morwell, 3840
286 Maryvale Rd. Morwell, 3840
T +61 3 5132 1283 | F +61 3 5132 1281
E jenny@maryvaleph.com.auMaryvale Private Hospital Confidentiality and Privacy Notice
NOTICE – This e-mail is only intended to be read by the named recipient. It may contain information which is confidential or proprietary. If you are not the intended recipient please notify the sender immediately and delete this e-mail. If you are not the intended recipient you should not copy this e-mail or use the information contained in it for any purpose nor disclose its contents to any other person. Maryvale Private Hospital Pty Ltd accepts no responsibility for electronic viruses or damage caused as a result of this email or for changes made to this email or to any attachments after transmission from Maryvale Private Hospital. You should not distribute or publish the contents of this email or any attachment without the prior consent of Maryvale Private Hospital.
* Please consider the environment before printing this email
MESSAGES POSTED TO THIS LIST ARE SOLELY THE OPINION OF THE AUTHOR, AND DO NOT REPRESENT THE OPINION OF ACIPC.The use of trade/product/commercial brand names through the list is discouraged by ACIPC. If you wish to discuss specific reference to products or services by brand or commercial names, please do this outside the list.
Archive of all messages are available at http://aicalist.org.au/archives – registration and login required.
Replies to this message will be directed back to the list. To create a new message send an email to aicalist@aicalist.org.au
To send a message to the list administrator send an email to aicalist-request@aicalist.org.au.
You can unsubscribe from this list be sending ‘signoff aicalist’ (without the quotes) to listserv@aicalist.org.au
This message is intended for the addressee named and may contain confidential information. If you are not the intended recipient, please delete it and notify the sender.
Views expressed in this message are those of the individual sender, and are not necessarily the views of NSW Health or any of its entities.
MESSAGES POSTED TO THIS LIST ARE SOLELY THE OPINION OF THE AUTHOR, AND DO NOT REPRESENT THE OPINION OF ACIPC.
The use of trade/product/commercial brand names through the list is discouraged by ACIPC. If you wish to discuss specific reference to products or services by brand or commercial names, please do this outside the list.
Archive of all messages are available at http://aicalist.org.au/archives – registration and login required.
Replies to this message will be directed back to the list. To create a new message send an email to aicalist@aicalist.org.au
To send a message to the list administrator send an email to aicalist-request@aicalist.org.au.
You can unsubscribe from this list be sending ‘signoff aicalist’ (without the quotes) to listserv@aicalist.org.au
